Literature DB >> 18172658

Retinoblastoma gene abnormalities in early laryngeal cancer.

Mark Rafferty1, Carol Walker, David Husband, Timothy Helliwell, John Fenton, Andrew Jones.   

Abstract

The retinoblastoma gene (Rb) is postulated to be important in carcinoma of the larynx. Its cellular protein (pRb) is involved in regulation of the cell cycle and may be influential in the cells response to irradiation injury. From the University of Liverpool Head and Neck Database we identified 35 patients with a T2 N0 laryngeal squamous carcinoma whom received primary irradiation and had a minimum of 5 years follow up. Laser capture microdissection was performed on paired normal and tumour biopsy material to analyse for loss of heterozygosity (LOH) and microsatellite instability (MI) of the Rb gene and immunohistochemistry (IHC) was carried out to detect pRb expression. Of 35 tumours, 13 were normal, 12 had MI and 5 had LOH of the Rb gene. Abnormalities at the Rb locus did not correlate with loss of pRb expression. There was also no significant difference between the distribution of normal and abnormal gene sequences and whether or not the primary laryngeal tumour recurred after radiotherapy. Rb gene abnormalities occurred in one third of T2 N0 laryngeal carcinomas. These were not in isolation predictive of cure by radiotherapy.

Entities:  

Mesh:

Year:  2008        PMID: 18172658     DOI: 10.1007/s00405-007-0558-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  12 in total

1.  Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.

Authors:  E P Xing; G Y Yang; L D Wang; S T Shi; C S Yang
Journal:  Clin Cancer Res       Date:  1999-05       Impact factor: 12.531

2.  Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.

Authors:  M K Dodson; W A Cliby; H J Xu; K A DeLacey; S X Hu; G L Keeney; J Li; K C Podratz; R B Jenkins; W F Benedict
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

3.  Frequent loss of heterozygosity for Rb, TP53, and chromosome arm 3p, but not NME1 in squamous cell carcinomas of the supraglottic larynx.

Authors:  S B Scholnick; P C Sun; M E Shaw; B H Haughey; S K el-Mofty
Journal:  Cancer       Date:  1994-05-15       Impact factor: 6.860

4.  Loss of retinoblastoma protein expression in laryngeal squamous cell carcinoma.

Authors:  H Mizokami; M Sawatsubashi; O Tokunaga; T Shin
Journal:  Mod Pathol       Date:  1999-01       Impact factor: 7.842

5.  Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas.

Authors:  H J Xu; S X Hu; P T Cagle; G E Moore; W F Benedict
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

6.  Abnormalities and the implication of retinoblastoma locus and its protein product in head and neck cancers.

Authors:  J Yokoyama; K Shiga; H Sasano; M Suzuki; T Takasaka
Journal:  Anticancer Res       Date:  1996 Mar-Apr       Impact factor: 2.480

7.  Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma.

Authors:  G H Yoo; H J Xu; J A Brennan; W Westra; R H Hruban; W Koch; W F Benedict; D Sidransky
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

8.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

9.  Inactivation of the retinoblastoma susceptibility gene in human breast cancers.

Authors:  E Y Lee; H To; J Y Shew; R Bookstein; P Scully; W H Lee
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

10.  Expression of p53 isoforms in squamous cell carcinoma of the head and neck.

Authors:  Linda Boldrup; Jean-Christophe Bourdon; Philip J Coates; Björn Sjöström; Karin Nylander
Journal:  Eur J Cancer       Date:  2007-01-09       Impact factor: 9.162

View more
  2 in total

Review 1.  A genetic view of laryngeal cancer heterogeneity.

Authors:  María José de Miguel-Luken; Manuel Chaves-Conde; Amancio Carnero
Journal:  Cell Cycle       Date:  2016-03-03       Impact factor: 4.534

2.  Biological tumor markers associated with local control after primary radiotherapy in laryngeal cancer: A systematic review.

Authors:  Maartje G Noordhuis; Emiel A Kop; Bert van der Vegt; Johannes A Langendijk; Bernard F A M van der Laan; Ed Schuuring; Geertruida H de Bock
Journal:  Clin Otolaryngol       Date:  2020-04-23       Impact factor: 2.597

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.